ORCID Profile
0000-0003-2947-5694
Current Organisations
University of Canterbury
,
University of Oxford
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: AIP Publishing
Date: 28-12-2018
DOI: 10.1063/1.5054355
Abstract: Size-controlled ZnO nanowires were grown by eclipse pulsed laser deposition using Au colloids and ultra-small (sub 2 nm) Au101 and Au9 clusters as catalysts, tethered to c-plane sapphire substrates using aminopropyltrimethoxysilane (APTMS). A strong correlation was observed between ZnO nanowire tip diameter and Au catalyst size, with no apparent lower limit to the size of Au nanoparticles able to catalyze nanowire growth. All ZnO nanowires produced intense ultraviolet photoluminescence with almost no visible defect band emission that is commonly observed in ZnO-based materials, including nanowires. A correlation was also observed between the quality of the ultraviolet photoluminescence (in terms of decreasing exciton line widths and surface-related emission) and decreasing ZnO nanowire diameter, with the highest quality emission obtained using Au9 atomically precise cluster catalysts, used here as catalysts for ZnO growth for the first time.
Publisher: Wiley
Date: 18-09-2012
DOI: 10.1111/J.1751-1097.2012.01221.X
Abstract: Self-reported sun exposure is commonly used in research, but how well this represents actual sun exposure is poorly understood. From February to July 2011, a volunteer s le (n = 47) of older adults (≥45 years) in Canberra, Australia, answered brief questions on time outdoors (weekdays and weekends) and natural skin color. They subsequently maintained a sun diary and wore an ultraviolet radiation (UVR) digital dosimeter for 7 days. Melanin density was estimated using reflectance spectrophotometry lifetime sun damage was assessed using silicone casts of the back of the hand and serum 25-hydroxyvitamin D (25(OH)D) concentration was assayed. Questionnaire-reported time outdoors correlated significantly with diary-recorded time outdoors (Spearman correlation r(s) = 0.66 95% CI 0.46, 0.80 P < 0.001) and UVR dosimeter dose (r(s ) = 0.46 95% CI 0.18, 0.68 P = 0.003), but not 25(OH)D concentration (r(s) = 0.24 95% CI -0.05, 0.50 P = 0.10). Questionnaire-reported untanned skin color correlated significantly with measured melanin density at the inner upper arm (r(s) = 0.49 95% CI 0.24, 0.68 P < 0.001). In a multiple linear regression model, statistically significant predictors of 25(OH)D concentration were self-reported frequency of physical activity, skin color and recent osteoporosis treatment (R(2) = 0.54). In this study, brief questionnaire items provided valid rankings of sun exposure and skin color, and enabled the development of a predictive model for 25(OH)D concentration.
Publisher: Elsevier BV
Date: 07-2019
DOI: 10.1016/J.JID.2018.12.025
Abstract: Animal and human studies show that exposure to solar-simulated UVR is immunomodulatory. Human studies that used natural sun exposure and controlled for confounding are rare. We immunized 217 healthy adults (age range = 18-40 years) with a T-cell-dependent antigen, keyhole limpet hemocyanin, and measured personal clothing-adjusted UVR exposure (for 5 days before and after immunization), lifetime cumulative UVR exposure, serum 25-hydroxyvitamin D concentration at immunization, and potential confounding factors. We tested cellular and humoral immune responses in relation to UVR exposure. The delayed-type hypersensitivity response to keyhole limpet hemocyanin recall challenge was lower in in iduals with higher personal clothing-adjusted UVR exposure on the day before immunization (P = 0.015) and during intervals spanning the day before to 2-3 days after immunization. There was an incremental increase in T helper type 17 cells (as a proportion of CD4
Publisher: Elsevier BV
Date: 05-2021
Publisher: Springer Science and Business Media LLC
Date: 30-06-2020
DOI: 10.1186/S13063-020-04351-W
Abstract: The Melanoma Genomics Managing Your Risk Study is a randomised controlled trial that aims to evaluate the efficacy of providing information on personal genomic risk of melanoma in reducing ultraviolet radiation (UV) exposure, stratified by traditional risk group (low or high phenotypic risk) in the general population. The primary outcome is objectively measured total daily Standard Erythemal Doses at 12 months. Secondary outcomes include UV exposure at specific time periods, self-reported sun protection and skin-examination behaviours, psychosocial outcomes, and ethical considerations surrounding offering genomic testing at a population level. A within-trial and modelled economic evaluation will be undertaken from an Australian health system perspective to assess the cost-effectiveness of the intervention. To publish the pre-determined statistical analysis plan (SAP) before database lock and the start of analysis. This SAP describes the data synthesis, analysis principles and statistical procedures for analysing the outcomes from this trial. The SAP was approved after closure of recruitment and before completion of patient follow-up. It outlines the planned primary analyses and a range of subgroup and sensitivity analyses. Health economic outcomes are not included in this plan but will be analysed separately. The SAP will be adhered to for the final data analysis of this trial to avoid potential analysis bias that may arise from knowledge of the outcome data. This SAP is consistent with best practice and should enable transparent reporting. This SAP has been developed for the Melanoma Genomics Managing Your Risk Study and will be followed to ensure high-quality standards of internal validity and to minimise analysis bias. Prospectively registered with the Australian New Zealand Clinical Trials Registry, ID: ACTR N12617000691347 . Registered on 15 May 2017.
Publisher: Wiley
Date: 2016
DOI: 10.1111/PHP.12551
Location: United Kingdom of Great Britain and Northern Ireland
Location: United Kingdom of Great Britain and Northern Ireland
Location: United States of America
No related grants have been discovered for Claire I.O. Nichols.